Smiths Group PLC: Navigating Soft Markets, High P/E, and Untapped Growth Across Defence, MedTech, and 5G
Smiths Group PLC faces a high‑P/E valuation amid softening markets, but its defence, medical, energy, and 5G sectors offer hidden growth opportunities and risks that savvy investors must assess.
4 minutes to read









